The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * Ford Motor Co has picked Mark Fields, its chief operating officer, to succeed Alan R. Mulally as the next chief executive of the company, according to a person with knowledge of the move. The selection of Fields would hasten the retirement of Mulally, who has said previously that he would stay as chief executive of Ford through the end of this year. (r.reuters.com/zes68v)* Activist investor William A. Ackman, among the brashest men on Wall Street, made perhaps the boldest move yet for an activist. By teaming up with Valeant Pharmaceuticals International Inc, a big health care company, and offering to purchase Allergan Inc, the maker of Botox, for roughly $50 billion. (r.reuters.com/bus68v)
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 6.03% or $8.08/share to $142.00. In the past year, the shares have traded as low as $81.33 and as high as $142.00. On average, 3082430 shares of AGN exchange hands on a given day and today's volume is recorded at 10559503.
Ford Motor Company (Ford) is a producer of automobiles. Shares of F fell by 0.13% or $-0.02/share to $15.98. In the past year, the shares have traded as low as $13.11 and as high as $18.02. On average, 35128200 shares of F exchange hands on a given day and today's volume is recorded at 24911768.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.24% or $3.96/share to $126.01. In the past year, the shares have traded as low as $71.99 and as high as $153.10. On average, 1992590 shares of VRX exchange hands on a given day and today's volume is recorded at 2789973.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.21% or $4.31/share to $138.76. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 372348 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 318584.
Source
